GL1X · GenesisL1 explorer

Research workbench

Von hippel lindau PROTEIN:ELONGINB:ELONGINC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methyl-1,2-oxazol-5-YL)ETHANOYL]-4-oxidanyl- pyrrolidine-2-carboxamide

Analyse Von hippel lindau PROTEIN:ELONGINB:ELONGINC complex, in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4BKT
Type
protein
Length
1,326 residues
Chains
12
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transcription elongation factor B polypeptide 2; Transcription elongation factor B…
UniProt
Q15370, Q15369, P40337
Ligands
QD0, GLU, ARG
Pockets
8 · best druggability 0.59

Structure

x-ray diffraction · 10 distinct chains · 27% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATranscription elongation factor B polypeptide 2protein10414% helix, 37% strandQ15370
B, ETranscription elongation factor B polypeptide 1protein8748% helix, 15% strandQ15369
CVon hippel-lindau disease tumor suppressorprotein13822% helix, 30% strandP40337
DTranscription elongation factor B polypeptide 2protein10215% helix, 35% strandQ15370
FVon hippel-lindau disease tumor suppressorprotein14127% helix, 30% strandP40337
G, JTranscription elongation factor B polypeptide 2protein10315% helix, 39% strandQ15370
HTranscription elongation factor B polypeptide 1protein8747% helix, 15% strandQ15369
IVon hippel-lindau disease tumor suppressorprotein14325% helix, 29% strandP40337
KTranscription elongation factor B polypeptide 1protein8747% helix, 15% strandQ15369
LVon hippel-lindau disease tumor suppressorprotein14424% helix, 29% strandP40337

Ligands and binding sites

  • QD0 · (2S,4R)-N-methyl-1-[2-(3-methyl-1,2-oxazol-5-yl)ethanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide · ligand · 4 copies · chains C, F, I, L
  • GLU · Glutamic acid · ligand · chains F
  • ARG · Arginine · ligand · chains I

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12340.590.7936QD0
22130.570.7934empty
3820.520.8420empty
41460.420.7523empty
51590.420.7424empty

Interfaces

16 interfaces between chains.

  • J–K · 1151 Ų buried · 15 hydrogen bonds · protein-protein
  • G–H · 1146 Ų buried · 15 hydrogen bonds · protein-protein
  • A–B · 1141 Ų buried · 14 hydrogen bonds · protein-protein
  • E–F · 1101 Ų buried · 11 hydrogen bonds · protein-protein
  • B–C · 1088 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 modified, 2 covalent (artifact, covalent ligand).

Compared structures

  • 4BKT · von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.